[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352213-105":59,"doc-detail-352213-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","yap1-induces-hepatocellular-carcinoma-via-dna-demethylation-rather-than-by-canonical-driver-gene-mutations","YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations","","Large-scale genome sequencing reveals driver gene mutations in most cancers, yet a small fraction lacks these canonical driver gene mutations, leaving their formation mechanisms unclear. The study tests whether canonical DGM-negative cancers can be driven by YAP1-TEAD activation that induces epigenetic changes. In a mouse hepatocellular carcinoma mosaic model, whole-exome sequencing shows no canonical DGMs, while bisulfite sequencing shows widespread DNA demethylation. Tet1 knockdown reduces tumor formation, and spatial transcriptomics identifies a Tet1-high HCC subpopulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/yap1-induces-hepatocellular-carcinoma-via-dna-demethylation-rather-than-by-canonical-driver-gene-mutations/352213/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/yap1-induces-hepatocellular-carcinoma-via-dna-demethylation-rather-than-by-canonical-driver-gene-mutations/352213.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about canonical DGM-negative cancers?","Question",{"text":112,"@type":113},"The study investigates how cancers form when they do not carry canonical driver gene mutations, focusing on whether YAP1-TEAD activation can induce epigenetic changes that drive tumorigenesis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers test the role of YAP1-TEAD in hepatocellular carcinoma?",{"text":117,"@type":113},"They established a mouse mosaic HCC model by inducing YAP1-TEAD activation in a few hepatocytes and then analyzed genomic and epigenetic changes.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence links YAP1-TEAD to DNA demethylation and oncogene activation?",{"text":121,"@type":113},"Whole-exome sequencing failed to identify canonical DGMs, while bisulfite sequencing revealed widespread DNA demethylation and transcriptional activation of multiple oncogenes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352213,1790123833,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","communications biology Article  \n\n| A Nature Portfolio journal |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s42003-026-10882-w](https://doi.org/10.1038/s42003-026-10882-w) |  |  |\n| YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations\u003Cbr> Check for updates |  |  |\n| Misaki Kosaka1,6, Yoshimi Okamoto-Uchida 1,6 , Haruka Hirose1,2,6, Yuya Nagaoka 1,\u003Cbr>Norio Miyamura 1, Akinori Kanai 3, Daiki Hatakeyama1, Michiko Nakagawa1, Miki Nishio4, Tomohiko Maehama 4,5, Akira Suzuki4, Yutaka Suzuki 3, Teppei Shimamura1  & Hiroshi Nishina 1  |  |  |\n| Large-scale genome sequencing analyses have identiﬁed driver gene mutations (DGMs) in most cancers as well as their associated tumorigenic mechanisms. However, a small fraction of cancers are not positive for these canonical DGMs, leaving the mechanisms underpinning their formation a mystery. We hypothesized that canonical DGM-negative cancers might be driven by activation of the transcriptional coactivatorYAP1that led to the induction of epigenetic changes. To test this theory, we established a mouse mosaic model of hepatocellular carcinoma (HCC) in which we induced YAP1-TEAD activation in a few hepatocytes. Whole-exome sequencing did not identify canonical DGMs in HCCs, but bisulﬁte sequencing revealed widespread DNA demethylation leading to the transcriptional activation of multiple oncogenes. Knockdown of the DNA demethylation-promoting gene, Tet1 , attenuated HCC formation in these mice. Single-cell spatial transcriptomics identiﬁed a Tet1-high subpopulation of HCC cells that interacted with other hepatic cell types. Our mechanistic mouse data align with the observation that YAP1–TEAD–TET1-associated signatures were also elevated in hepatocytes from patients with Fontan-associated liver disease (FALD), a condition associated with the development of HCCs with lower frequencies of canonical DGMs. Our study suggests that the YAP1-TEAD-TET1 axis promotes canonical DGM-negative HCC development, and provides new insights into the molecular processes involved. |  |  |\n| Most cancers arise from rogue cells characterized by the activation of proteins encoded by oncogenes or the inactivation of proteins encoded by tumor suppressor genes1,2. These genes are commonly referred to as “driver genes”, and the functional changes they cause are typically attributed to DNA mutations. Recent large-scale whole-genome sequencing (WGS) efforts have shed light on the landscape of driver gene mutations (DGMs) linked to tumorigenesis. For instance, a pan-cancer analysis of over 2600 tumors across 38 types identiﬁed DGMs in >90% of cases, underscoring the importance of mutations to coding sequences3. However, approximately 5% of these tumors were negative for canonical DGMs, even after accounting for potential technical limitations in mutation-calling3,4. Asubsequent highdepth WGS analysis of 494 hepatocellular carcinoma (HCC) samples | revealed the existence of canonical DGM-negative HCCs5. In particular, lower frequencies of canonical DGMs were found in HCCs linked to Fontan-associated liver disease (FALD), which arises after the Fontan procedure is used to treat congenital heart disease6–10. In FALD patients, the liver is subjected to persistent hemodynamic stress due to chronically elevated central venous pressure, leading to the development of both HCCsand intrahepatic cholangiocarcinoma (ICC)6–9. Recent studies have reported some genomic mutations in FALD-associated HCCs8,10. However, canonical HCC DGMs, including CTNNB1, TP53, and TERT promoter mutations, were less frequent in FALD-associated HCCs than in other types of HCCs10. These ﬁndings imply that HCCs can be induced by alternative mechanisms that can drive carcinogenesis independently of genomic canonical DGMs11. |  |\n\n1Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan. 2Laboratory of Computational Life Science, National Cancer Center Re","cbCaiuiA4Ij5kBez","https://ap.wps.com/l/cbCaiuiA4Ij5kBez","pdf",7948419,"English","# YAP1-TEAD activation and DGM-negative HCC\n## Mouse mosaic model of hepatocellular carcinoma\n## DNA demethylation, Tet1, and oncogene activation\n## Single-cell spatial transcriptomics and patient signatures","[{\"question\":\"What question does the study address about canonical DGM-negative cancers?\",\"answer\":\"The study investigates how cancers form when they do not carry canonical driver gene mutations, focusing on whether YAP1-TEAD activation can induce epigenetic changes that drive tumorigenesis.\"},{\"question\":\"How did the researchers test the role of YAP1-TEAD in hepatocellular carcinoma?\",\"answer\":\"They established a mouse mosaic HCC model by inducing YAP1-TEAD activation in a few hepatocytes and then analyzed genomic and epigenetic changes.\"},{\"question\":\"What evidence links YAP1-TEAD to DNA demethylation and oncogene activation?\",\"answer\":\"Whole-exome sequencing failed to identify canonical DGMs, while bisulfite sequencing revealed widespread DNA demethylation and transcriptional activation of multiple oncogenes.\"}]","YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations | PDF",1790098331,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/188698f638e01f4ae0b98f3cd67bdc89.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52169dda8e76c6f1d85c8ed6daeb147a.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9ffa3bccf9652c1e0cb1126516acf48.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b5cc2047bcd1e9f579d5e56eff03199.webp",980,1301]